Pharmacologic management of migraine--1985.
Kunkel
R S
RS
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008784:Methysergide / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D011942:Receptors, Adrenergic, alpha; D014665:Vasodilator Agents; D016651:Lithium Carbonate; D004087:Dihydroergotamine; D008094:Lithium; D008787:Metoclopramide; D008784:Methysergide